* Idec Pharmaceuticals Corp. of San Diego...

* Idec Pharmaceuticals Corp. of San Diego said third-quarter profit rose 43% to $38.4 million, or 22 cents a share. Revenue increased 49% to $103.7 million, boosted by sales of Rituxan, which Idec developed with Genentech.